San Diego, CA, United States of America

Marshall Morningstar



Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 48(Granted Patents)


Location History:

  • San Diego, MD (US) (2002)
  • San Diego, CA (US) (2002 - 2008)
  • Framingham, MA (US) (2008)
  • Cambridge, MA (US) (1999 - 2024)

Company Filing History:


Years Active: 1999-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Marshall Morningstar

Introduction

Marshall Morningstar, located in San Diego, CA, is a distinguished inventor recognized for his significant contributions to the field of medical research and pharmaceutical innovations. With a remarkable portfolio of ten patents, he has dedicated his career to developing compounds aimed at combating various parasitic diseases.

Latest Patents

Among his latest patents is a groundbreaking innovation titled "Compounds and methods for the treatment of parasitic diseases." This patent describes novel compounds that are useful in treating ailments caused by parasites, such as malaria and cryptosporidiosis. These compounds, along with their pharmaceutically acceptable salts, can be formulated into both pharmaceutical and veterinary compositions, highlighting their versatility and potential impact on global health.

Career Highlights

Marshall has had a remarkable career, having worked at prestigious institutions including the Massachusetts Institute of Technology and the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. His work in these esteemed organizations has positioned him as a leader in his field, making significant strides towards improving treatments for parasitic diseases.

Collaborations

Throughout his career, Marshall Morningstar has collaborated with esteemed colleagues such as John M. Essigmann and Robert G. Croy. These collaborations have facilitated the exchange of ideas and expertise, further advancing the research and development of his innovative compounds.

Conclusion

In conclusion, Marshall Morningstar's dedication to innovation and his impressive patent portfolio reflect his commitment to combating parasitic diseases. His work continues to inspire and pave the way for future advancements in the pharmaceutical field, ultimately contributing to the health and well-being of countless individuals affected by these diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…